New research suggests stopping GLP-1 drugs may bring back more than weight, with heart risks rising after treatment gaps.
Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results